WHO study shows Remdesivir has "little or no effect" in preventing COVID-19 deaths
The antiviral drug has been considered one of the most promising COVID-19 treatments and was among those given to President Trump when...
Full Article
WHO study shows Remdesivir has "little or no effect" in preventing COVID-19 deaths
Upworthy
0 shares
1 views
You might like
Related news coverage
WHO and USFDA views on repurposed meds start a debate
Mid-Day
The World Health Organisation (WHO) and the US Food and Drug Administration (USFDA) have taken opposite stands on repurposed..
-
Group calls for end to 'cozy' and 'unacceptable' relationship between senior government officials and Facebook
National Post
-
Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors
-
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
Mid-Day
-
US gives full approval for antiviral remdesivir drug to treat COVID-19 patients
Mid-Day
Advertisement
More coverage
FDA Approves Remdesivir as First Therapeutic Treatment for Covid — One Week After WHO Concludes Drug Has ‘Little to No Effect’ on Patient Survival
Mediaite
FDA approves Remdesivir as first therapeutic treatment for Covid — one week after WHO concludes drug has 'little to no effect' on..
-
Covid: US gives full approval for antiviral remdesivir drug
BBC News
-
Remdesivir: Drug used to treat Donald Trump found to have 'little to no effect' on COVID-19 survival
euronews
-
Remdesivir, Hydroxychloroquine Have Little or No Effect on Severe COVID-19 Cases, WHO Says
VOA News
-
Anti-viral drug remdesivir has little to no effect on Covid patients' chances of survival, a study from the World Health Organization...
Upworthy